Frontlight ResearchEarly access
Taking people in NetherlandsPhase 1
Imaging test with FAPI to identify a colorectal cancer subtype
Tests a FAPI scan in adults with colorectal cancer spread to the liver.
Key facts
- Who runs it
- Universitair Medisch Centrum Utrecht
- Where
- Utrecht, NetherlandsSee the site
- Trial code
- Registry title
- Molecular imaging with FAPI for diagnosing the CSM4 colorectal cancer subtype
- Status
- Recruiting
- Phase
- Phase 1
- People taking part
- 45 people, planned
- Started
- 1 Aug 2024
- Expected to end
- 28 Jul 2031
- Type of study
- Interventional
- Record updated
- 12 September 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with colorectal cancer that has spread to the liver. It studies FAPI molecular imaging to find the CSM4 colorectal cancer subtype.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Disease stage
- Colorectal cancer with liver metastases.
Where in Netherlands
- Universitair Medisch Centrum UtrechtUtrecht, NetherlandsTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Plain-language title
- Imaging test with FAPI to identify a colorectal cancer subtypeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 12 September 2025